Literature DB >> 16250690

Clinically relevant cholesterol elevation in anxiety disorders: a comparison with normal controls.

H Peter1, P Goebel, S Müller, I Hand.   

Abstract

Recently, several studies reported elevated cholesterol levels in panic disorder, agoraphobia, and general anxiety disorder, but the clinical relevance is still unsettled. All studies so far have disregarded the possible influence of dietary and physical exercise factors. In this study, 30 patients with different anxiety disorders and 30 normal controls were compared for total cholesterol, low-density lipoprotein (LDL), and cholesterol high-density lipoprotein (HDL) ratio. Dietary and physical exercise habits were measured by self-rating questionnaires. Patients with anxiety disorders had significantly elevated total cholesterol, LDL, and cholesterol/HDL ratios. Patients showed borderline-high or high cholesterol levels almost 3 times as often as control participants. Anxiety-specific avoidance of physical exercise and special dietary habits of anxiety patients had a significant but minor impact on differences in cholesterol between both groups. Our data support the assumption that serum cholesterol elevations in anxiety disorder patients are within a clinically relevant range.

Entities:  

Year:  1999        PMID: 16250690     DOI: 10.1207/s15327558ijbm0601_3

Source DB:  PubMed          Journal:  Int J Behav Med        ISSN: 1070-5503


  26 in total

1.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

2.  Serum cholesterol, blood pressure, and mortality: implications from a cohort of 361,662 men.

Authors:  M J Martin; S B Hulley; W S Browner; L H Kuller; D Wentworth
Journal:  Lancet       Date:  1986-10-25       Impact factor: 79.321

3.  Panic disorder and cardiovascular/cerebrovascular problems: results from a community survey.

Authors:  M M Weissman; J S Markowitz; R Ouellette; S Greenwald; J P Kahn
Journal:  Am J Psychiatry       Date:  1990-11       Impact factor: 18.112

4.  High cholesterol levels in patients with panic disorder.

Authors:  A Reifman; M Windle
Journal:  Am J Psychiatry       Date:  1993-03       Impact factor: 18.112

5.  Plasma lipid levels and psychologic characteristics in men.

Authors:  D S Freedman; T Byers; D H Barrett; N E Stroup; E Eaker; H Monroe-Blum
Journal:  Am J Epidemiol       Date:  1995-03-15       Impact factor: 4.897

6.  Phobic anxiety and ischaemic heart disease.

Authors:  A P Haines; J D Imeson; T W Meade
Journal:  Br Med J (Clin Res Ed)       Date:  1987-08-01

7.  High cholesterol levels in patients with panic disorder.

Authors:  W K Bajwa; G M Asnis; W C Sanderson; A Irfan; H M van Praag
Journal:  Am J Psychiatry       Date:  1992-03       Impact factor: 18.112

Review 8.  Lipids in psychological research: the last decade.

Authors:  R Niaura; C M Stoney; P N Herbert
Journal:  Biol Psychol       Date:  1992-10       Impact factor: 3.251

9.  Plasma lipid levels in patients with panic disorder or agoraphobia.

Authors:  C Hayward; C B Taylor; W T Roth; R King; W S Agras
Journal:  Am J Psychiatry       Date:  1989-07       Impact factor: 18.112

10.  Mortality in a follow-up of 500 psychiatric outpatients. I. Total mortality.

Authors:  R L Martin; C R Cloninger; S B Guze; P J Clayton
Journal:  Arch Gen Psychiatry       Date:  1985-01
View more
  1 in total

1.  Chromosomal assignment of quantitative trait loci influencing baseline circulating total cholesterol level in male laboratory mice: report of a consomic strain survey and comparison with published results.

Authors:  Hein A van Lith; Marijke C Laarakker; José G Lozeman-van't Klooster; Frauke Ohl
Journal:  BMC Res Notes       Date:  2015-04-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.